Get the Stockscreener App
51.96
1.09%
0.56
Hims Hers Health Inc stock is traded at $51.96, with a volume of 62.13M.
It is up +1.09% in the last 24 hours and up +76.20% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$51.40
Open:
$49.43
24h Volume:
62.13M
Relative Volume:
1.86
Market Cap:
$9.14B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
118.09
EPS:
0.44
Net Cash Flow:
$149.62M
1W Performance:
+27.29%
1M Performance:
+76.20%
6M Performance:
+121.96%
1Y Performance:
+302.17%
1-Day Range:
$48.87
$52.22
1-Week Range:
$38.21
$54.75
52-Week Range:
$12.07
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
51.96 | 9.14B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
157.66 | 376.35B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
62.50 | 155.93B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
89.81 | 73.33B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
24.44 | 46.01B | 15.46B | 1.03B | 1.34B | 0.53 |
|
KMB
Kimberly Clark Corp
|
133.05 | 43.25B | 19.75B | 2.47B | 2.39B | 7.34 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed This Week - Insider Monkey
Massive Hims & Hers News: $1 Billion on AI and Acquisitions - Nasdaq
Hims & Hers Health (NYSE:HIMS) Appoints Mo Elshenawy As New CTO For AI-Driven Healthcare Transformation - Yahoo Finance
Hims & Hers Stock Surges On Strong Q1 Results, Falls After Convertible Note Offering - Benzinga
Hims & Hers Announces $450M Convertible Notes Offering - TipRanks
Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS) - Yahoo Finance
Hims & Hers Prices $870 Million Convertible Notes to Fund Expansion - marketscreener.com
Hims & Hers Health prices upsized $870M convertible senior notes - msn.com
Hims & Hers (HIMS) Doubles Down on AI & Global Growth with $870M Boost - TipRanks
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - 01net
Hims CEO Rides Weight-Loss Drug Boom to $1.1 Billion Fortune - MSN
Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage) - MSN
Digital health companies faced a rocky start to 2025 - Modern Healthcare
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started - Benzinga
Hims & Hers names Amazon veteran as COO - Healthcare Dive
Hims & Hers hires former Amazon exec as Q1 revenue doubles - Retail Dive
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer - 01net
Hims & Hers: The Road To Blue Chip Status (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Is Sliding Thursday: What's Going On? - Benzinga
Hims & Hers Health to offer $450M convertible senior notes - MSN
Hims & Hers plans $450M convertible notes offering By Investing.com - Investing.com Canada
Hims & Hers shares fall on convertible notes offering By Investing.com - Investing.com Canada
Hims & Hers shares fall on convertible notes offering - Investing.com
Hims & Hers plans $450M convertible notes offering - Investing.com
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - Yahoo Finance
After Leaping 89% Hims & Hers Health, Inc. (NYSE:HIMS) Shares Are Not Flying Under The Radar - simplywall.st
Hims & Hers appoints Mo Elshenawy as CTO to boost AI healthcare - Investing.com
Hims & Hers Has a Superpower in Healthcare - Nasdaq
How much a $1,000 investment in Hims & Hers at its IPO would be worth now - MSN
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy? - Yahoo Finance
Cofounder Of Hims, Seller Of Hair Loss And Erectile Dysfunction Pills, Is A Billionaire After Weight Loss Drug Deal - Forbes
Hims & Hers: 2030 Guidance Indicates Big Upside (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook - Benzinga
Surging Earnings Estimates Signal Upside for Hims & Hers Health (HIMS) Stock - Nasdaq
Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers Shows It's More Than Just GLP-1 Drugs - 24/7 Wall St.
Hims & Hers Health Inc. (HIMS) Stock: Monster Q1 Growth Can't Save Stock from After-Hours Tumble - CoinCentral
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript - MSN
Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy) - Seeking Alpha
Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth - The Motley Fool
Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday - Insider Monkey
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth - Yahoo Finance
What's Next For HIMS Stock After An Upbeat Q1? - Nasdaq
This Week's Healthcare Earnings: Moderna, CVS, Hims & Hers - Law360
Hims & Hers Health, Inc. Reports Strong Q1 Earnings - TipRanks
Piper Sandler Raises Price Target for Hims & Hers Health (HIMS) to $39.00 | HIMS Stock News - GuruFocus
Hims & Hers Health (HIMS) Surges 18.12%: What’s Fueling the Rally? - Wealth Daily
Stock Movers: Palantir, Hims, Constellation Energy - Bloomberg.com
What’s driving the roller-coaster ride for San Francisco’s Hims & Hers stock? - San Francisco Chronicle
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why - Yahoo Finance
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):